-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Neurotrophic factors and Parkinson's disease
Rajat Bhardwaj and Rahul Deshmukh
Review Article: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
A note on conditional and unconditional allocation concealment
Vance W Berger
Clinical Trail Perspective: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 5
Acknowledgements: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for anti-atherosclerotic drugs
Therese M Heinonen, Donald M Black
Review Article: Clinical Investigation